Every time Hannah publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...

Researchers at the Laureate Institute for Brain Research (LIBR) in Tulsa, Okla., have identified an abnormal link between the autonomic and central nervous systems, specifically via communication ...

Credit: Getty Images. Lexapro is a selective serotonin reuptake inhibitor. The Food and Drug Administration (FDA) has approved Lexapro (escitalopram) for the treatment of generalized anxiety disorder ...

New data reveals a rising trend in generalized anxiety disorder (GAD) prevalence among U.S. adults, emphasizing the need for improved diagnosis and treatment. It was found that more than one in ten ...

Anxiety disorders are a group of disorders that share symptoms like excessive fear and heightened stress (American Psychological Association [APA], 2022). It is important to note that fear and anxiety ...

Please provide your email address to receive an email when new articles are posted on . Treatment of generalized anxiety disorder with an antidepressant increased the treatment response rate by 41%.

Findings showed the 100mcg dose met the primary endpoint demonstrating a statistically significant 7.6-point reduction in HAM-A score at week 4 compared with placebo. The Food and Drug Administration ...

A study of individuals with generalized anxiety disorder in China found that they exhibit unusual patterns of affective inhibition and perform worse on tasks requiring affective shifting, compared to ...

MARLBOROUGH, Mass. & PRINCETON, N.J.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion) and Otsuka Pharmaceutical Development & Commercialization, Inc. (Otsuka) today announced that the first ...